Fabio Calabro
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors.
Journal: European urology open science
Published: June 08, 2026
Cytoreductive nephrectomy in the era of immune-checkpoint inhibitors: back to the future?
Journal: BJU international
Published: February 12, 2026
Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study.
Journal: NPJ breast cancer
Published: January 23, 2026
Challenges and advances in drug resistance and tolerance in cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 21, 2026
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy.
Journal: Clinical drug investigation
Published: December 09, 2025
A daily clinical practice decision-making overview for the present metastatic renal cell carcinoma (mRCC) management landscape.
Journal: Critical reviews in oncology/hematology
Published: October 14, 2025
Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 14, 2025
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 17, 2025
Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?
Journal: Frontiers in immunology
Published: July 16, 2025
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study.
Journal: JCO global oncology
Published: July 08, 2025
Last Updated: 09/26/2026